Richard Melsheimer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Ulcerative Colitis

Prognostic Factors

Patient Reported Outcomes

Drug Administration

Top Venues

Arquivos de gastroenterologia

Biologics : targets & therapy

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Aniela Bonorino Xexeo Castelo Branco, Wilton Argolo, Nathalia Santos, Gabriela Hernandez, Adriana Maria Kakehasi, Carlos Walter Sobrado Junior, Richard Melsheimer
ADHERENCE AND PERSISTENCE TO TREATMENT WITH INFLIXIMAB: ANALYSIS OF A PATIENT SUPPORT PROGRAM COHORT IN BRAZIL. Arquivos de gastroenterologia 61 (2024)
Aniela Bonorino Xexeo Castelo Branco, Wilton Argolo, Nathalia Santos, Gabriela Hernandez, Adriana Maria Kakehasi, Carlos Walter Sobrado Junior, Richard Melsheimer
ADHERENCE AND PERSISTENCE TO TREATMENT WITH INFLIXIMAB: ANALYSIS OF A PATIENT SUPPORT PROGRAM COHORT IN BRAZIL. Arquivos de gastroenterologia 61 (2024)
Iris Lin, Richard Melsheimer, Rachel H Bhak, Patrick Lefebvre, Maral DerSarkissian, Bruno Emond, Angela Lax, Catherine Nguyen, Melody Wu, Yinong Young-Xu
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Current medical research and opinion 38 (4) (2022)
Timothy Fitzgerald, Richard Melsheimer, Marie-Hélène Lafeuille, Patrick Lefebvre, Laura Morrison, Kimberly Woodruff, Iris Lin, Bruno Emond
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab. Biologics : targets & therapy 15 (2021)
Richard Melsheimer, Anja Geldhof, Isabel Apaolaza, Thomas Schaible
Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics : targets & therapy 13 (2019)